4.83 -0.00 (-0.01%)
After hours: 4:11PM EST
|Bid||4.78 x 45900|
|Ask||4.93 x 27000|
|Day's Range||4.79 - 4.87|
|52 Week Range||4.50 - 7.57|
|Beta (3Y Monthly)||1.07|
|PE Ratio (TTM)||10.64|
|Earnings Date||Jan 25, 2017 - Feb 1, 2017|
|Forward Dividend & Yield||0.16 (3.27%)|
|1y Target Est||6.00|
November 16, 2018 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and an application submitted by Sanofi.
Campos Neto, Treasury director for the Americas at Banco Santander, will replace Ilan Goldfajn, according to a text message from incoming Finance Minister Paulo Guedes. The appointment needs to be approved by Congress.
November 11, 2018 - New analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association (AHA) Scientific Sessions 2018. Praluent® (alirocumab) was associated with fewer deaths from any cause among patients who had previously experienced a heart attack or unstable angina (known as acute coronary syndrome, or ACS), and this was enhanced in patients who were followed for at least 3 years and those who had an LDL-C (low-density lipoprotein cholesterol) of 100 mg/dL or higher at baseline.
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial Praluent significantly reduced major adverse.
The government announcement was a response to the popular and political outrage that followed a court decision last night that home buyers should pay the tax. Prime Minister Pedro Sanchez said the government regrets the Supreme Court decision handed down late Tuesday, and that it will make banks pay the tax from the moment it publishes a decree on the matter. “Never again will Spaniards pay the tax,” Sanchez said at a news conference in Madrid on Wednesday.
November 6, 2018 - The U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) in adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis, whose disease was inadequately controlled with topical therapies or for whom topical treatment was medically inadvisable. Currently, there are no FDA-approved systemic biologic medicines to treat adolescents with moderate-to-severe atopic dermatitis.
Bank investors seem to be spooked by Turkey, but they may be overreacting. That is one lesson you could draw from the share-price reactions to third-quarter results from two Spanish banks.
November 1, 2018 - Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to treat a range of neurological and systemic inflammatory diseases. The two lead molecules (DNL747 and DNL758) target a critical signaling protein known as the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the TNF receptor pathway, which regulates inflammation and cell death in tissues throughout the body.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it practical, we’ll show how Banco Santander SA’s (BME:SAN) Read More...
Key HighlightsA positive surprise was the building of capital with 31 basis points added to fully-loaded core equity Tier 1 in the quarter, taking the measure to 11.11 percent. The election of Jair Bolsonaro has raised hopes he’ll implement reforms that will boost Santander’s largest market, and the real has recently pared losses.The U.K. showed signs of stabilizing after a tough regulatory environment and uncertainty surrounding Brexit weighed on the business in prior quarters. Santander has had to invest money in projects such as ring-fencing, which obliges banks to separate investment arms from retail banking.
Banco Santander SA’s (SAN.MC) third-quarter net profit grew strongly from a year earlier, when it reported a number of one-off charges. Net profit for the period rose roughly 36% to 1.99 billion euros ($2.
The euro zone's largest bank by market value posted attributable net profit of 1.99 billion euros ($2.256 billion) for the three-month period ending Sept. 30. Analysts at data firm Refinitiv had been expecting third-quarter net profit to come in at around 1.98 billion euros. Like Spanish rival BBVA, Santander makes most of its profit overseas, a model that has helped the bank counter a double-dip recession at home in recent years.
FDA approves asthma indication for Dupixent® (dupilumab) Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic.
Dengue fever is a debilitating disease typically leading to prolonged fever and severe joint pain. Dengue infection can progress unpredictably to a life-threatening form of the disease called dengue haemorrhagic fever that often requires hospitalized care. Today, there is no specific treatment available for dengue disease.
The Spanish lender confirmed on Thursday that it is being investigated and said it is fully cooperating. It has also started an internal investigation to look into the allegations. A group of cooperating media organizations from a dozen countries, including Spanish newspaper El Confidencial, reported the news earlier, along with some other fresh details.
Seven banks, including HSBC (HSBA.L) and Banco Santander (SAN.MC), have signed a Memorandum of Understanding (MoU) to create a global digital network in trade finance aiming at allowing cheaper and easier funding for corporates, a Santander manager said on Wednesday. The Australia and New Zealand Banking Group ANZ (ANZ.AX), BNP Paribas (BNPP.PA), Citibank (C.N), Standard Chartered and Deutsche Bank (DBKGn.DE) also agreed to join the digital trade information network expected to be operational by the third quarter of next year. "It is the first time that these banks come together to set a standard (...) that will allow cheaper access to finance because the risks are going to be reduced," Rogier Schulpen, global head of trade and working solutions at Banco Santander, said in a phone interview.
Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps Dupixent significantly reduced nasal.
Ripple said that xRapid, which uses the cryptocurrency XRP to carry out international transactions, is now commercially available.
With a €72.18b market capitalisation, Banco Santander SA (BME:SAN) falls in the large, commercial bank category. A common risk large financial institutions face is credit risk, measured by the level Read More...
Banco Santander SA named UBS Group AG’s Andrea Orcel as its new CEO, propelling one of Europe’s highest-profile investment bankers to the helm of a global banking giant. Santander said Mr. Orcel will take over early next year from José Antonio Álvarez, who has been in the job since 2015. Mr. Álvarez will become vice chairman of the Santander group and executive chairman for Santander Spain, the bank said.
SA has reached an agreement to sell a portfolio of residential properties to an affiliate of Cerberus Capital Management LP for about 1.54 billion euros ($1.80 billion), the bank said Wednesday. “This portfolio of foreclosed properties consists of 35,700 residential properties and associated parking and storage and will be serviced by Haya Real Estate, a property-management company affiliated with the Cerberus group,” it said.